Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myuri Ruthirakuhan

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Journal of Neurochemistry|June 12, 2026
Targeting Brain Cholesterol Homeostasis in Alzheimer's Disease: Mechanisms and Therapeutic PerspectivesMyuri Ruthirakuhan, Ameer Y Taha, Walter Swardfager
The Journal of Clinical Psychiatry|February 13, 2019
Natural and Synthetic Cannabinoids for Agitation and Aggression in Alzheimer's Disease: A Meta-AnalysisMyuri Ruthirakuhan, Krista L Lanctôt, Danielle Vieira, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 1, 2022
Mild behavioral impairment is associated with progression to Alzheimer's disease: A clinicopathological studyMyuri Ruthirakuhan, Zahinoor Ismail, Nathan Herrmann, et al.
Current Opinion in Psychiatry|December 20, 2017
Cannabinoids for the treatment of neuropsychiatric symptoms, pain and weight loss in dementiaChelsea Sherman, Myuri Ruthirakuhan, Danielle Vieira, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|March 27, 2019
The Roles of Apathy and Depression in Predicting Alzheimer Disease: A Longitudinal Analysis in Older Adults With Mild Cognitive ImpairmentMyuri Ruthirakuhan, Nathan Herrmann, Danielle Vieira, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 27, 2025
Updates and future perspectives on neuropsychiatric symptoms in Alzheimer's diseaseMyuri Ruthirakuhan, Dylan X Guan, Moyra Mortby, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 26, 2018
Biomarkers of agitation and aggression in Alzheimer's disease: A systematic reviewMyuri Ruthirakuhan, Krista L Lanctôt, Matteo Di Scipio, et al.
Neurodegenerative Disease Management|July 25, 2018
Psychometric properties of apathy scales in Parkinson's disease: a systematic reviewDana Mohammad, Courtney Ellis, Allison Rau, et al.
Journal of Aging Research|February 1, 2013
Use of physical and intellectual activities and socialization in the management of cognitive decline of aging and in dementia: a reviewMyuri Ruthirakuhan, Angela C Luedke, Angela Tam, et al.
CNS Drugs|August 15, 2015
Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer's DiseaseCelina S Liu, Sarah A Chau, Myuri Ruthirakuhan, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Journal of Neurochemistry|June 12, 2026
Targeting Brain Cholesterol Homeostasis in Alzheimer's Disease: Mechanisms and Therapeutic PerspectivesMyuri Ruthirakuhan, Ameer Y Taha, Walter Swardfager
The Journal of Clinical Psychiatry|February 13, 2019
Natural and Synthetic Cannabinoids for Agitation and Aggression in Alzheimer's Disease: A Meta-AnalysisMyuri Ruthirakuhan, Krista L Lanctôt, Danielle Vieira, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 1, 2022
Mild behavioral impairment is associated with progression to Alzheimer's disease: A clinicopathological studyMyuri Ruthirakuhan, Zahinoor Ismail, Nathan Herrmann, et al.
Current Opinion in Psychiatry|December 20, 2017
Cannabinoids for the treatment of neuropsychiatric symptoms, pain and weight loss in dementiaChelsea Sherman, Myuri Ruthirakuhan, Danielle Vieira, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|March 27, 2019
The Roles of Apathy and Depression in Predicting Alzheimer Disease: A Longitudinal Analysis in Older Adults With Mild Cognitive ImpairmentMyuri Ruthirakuhan, Nathan Herrmann, Danielle Vieira, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 27, 2025
Updates and future perspectives on neuropsychiatric symptoms in Alzheimer's diseaseMyuri Ruthirakuhan, Dylan X Guan, Moyra Mortby, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 26, 2018
Biomarkers of agitation and aggression in Alzheimer's disease: A systematic reviewMyuri Ruthirakuhan, Krista L Lanctôt, Matteo Di Scipio, et al.
Neurodegenerative Disease Management|July 25, 2018
Psychometric properties of apathy scales in Parkinson's disease: a systematic reviewDana Mohammad, Courtney Ellis, Allison Rau, et al.
Journal of Aging Research|February 1, 2013
Use of physical and intellectual activities and socialization in the management of cognitive decline of aging and in dementia: a reviewMyuri Ruthirakuhan, Angela C Luedke, Angela Tam, et al.
CNS Drugs|August 15, 2015
Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer's DiseaseCelina S Liu, Sarah A Chau, Myuri Ruthirakuhan, et al.
Pageof 4